Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes In Stockholders??? Equity

v3.20.1
Condensed Consolidated Statements of Changes In Stockholders’ Equity - USD ($)
$ in Thousands
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Beginning balance at Dec. 31, 2018 $ 8 $ 37,880 $ (35,067) $ 2,821
Beginning balance, shares at Dec. 31, 2018 7,481,723      
Proceeds from sale of common stock 212 212
Proceeds from sale of common stock, shares 111,129      
Proceeds from private placement of common stock $ 1 1,849 1,850
Proceeds from private placement of common stock, shares 1,267,123      
Issuance of common stock upon exchange of related party promissory note payable 250 250
Issuance of common stock upon exchange of related party promissory note payable, shares 171,233      
Stock-based compensation expense 42 42
Stock-based compensation expense, shares      
Issuance of restricted common stock 201 201
Issuance of restricted common stock, shares 139,450      
Net loss (975) (975)
Ending balance at Mar. 31, 2019 $ 9 40,434 (36,042) 4,401
Ending balance, shares at Mar. 31, 2019 9,170,658      
Beginning balance at Dec. 31, 2019 $ 9 40,496 (39,325) 1,180
Beginning balance, shares at Dec. 31, 2019 9,176,908      
Proceeds from sale of common stock 228 228
Proceeds from sale of common stock, shares 147,407      
Proceeds from private placement of common stock $ 1 1,029 1,030
Proceeds from private placement of common stock, shares 851,240      
Issuance of common stock upon exchange of related party promissory note payable $ 1 824 825
Issuance of common stock upon exchange of related party promissory note payable, shares 681,818      
Stock-based compensation expense 8 8
Stock-based compensation expense, shares      
Issuance of restricted common stock 209 209
Issuance of restricted common stock, shares 172,727      
Net loss (866) (866)
Ending balance at Mar. 31, 2020 $ 11 $ 42,794 $ (40,191) $ 2,614
Ending balance, shares at Mar. 31, 2020 11,030,100